REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/04/2026
Back to search
Official data from USPTO
MEZZION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
05/05/2026
Trademark type
Combined
Nice classes
5, 41, 42, 44
Filing date
11/08/2018
Registration date
05/04/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/04/2021
Last transaction
05/05/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
3
Owner type
99
Owner location
Seoul, KR
Examiner
MARTIN, CHRISTINE C
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The word "MEZZION" with the "O" replaced with an open ended heart with a stylized image of a person therein closing the heart shape.
Holders and representatives
Holders
Mezzion Pharma Co., Ltd.
Representatives
Daniel R. Mello Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Technical classification
Nice Classes
Class 5Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of diseases and disordersPharmaceutical preparations for the treatment of cardiac diseases and disorders; Pharmaceutical preparations for the treatment of cardiac diseases and disorderssingle ventricle heart disease (SVHD)including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac diseasesingle ventricle heart disease (SVHD); pharmaceuticalsdrugs for the treatment of cardiac diseasesingle ventricle heart disease (SVHD)including SVHD subjects who have undergone Fontan Palliation
Class 41
Educational servicesseminars in the field of pharmaceuticalsmedicinehealthwellbeingcardiac issues and distribution of course materials in connection therewith; providing a website featuring blogs in the field of pharmaceuticalsmedicinehealthwellbeingcardiac issues
Class 42
Medical and pharmaceutical research for the treatment of cardiac disease and disorderssingle ventricle heart disease (SVHD)including SVHD subjects who have undergone Fontan Palliation and product development services; scientific and technological research services related theretoscientific research services for the treatment of cardiac disease and disorderssingle ventricle heart disease (SVHD)including SVHD subjects who have undergone Fontan Palliation; medical testing servicesproviding medical testing services and information in the field of the treatment of cardiac disease and disorder researchsingle ventricle heart disease (SVHD) researchincluding SVHD subjects who have undergone Fontan Palliation for medical research purposes; conducting clinical trials for others; providing a website featuring medical and scientific research information in the field of pharmaceuticals and medicine
Class 44
Providing websites featuring information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals and medicinehealthwellnesscardiac health issues; Medical testing and screening servicesmedical diagnostic testing services and medical screening the treatment of cardiac disease and disorderssingle ventricle heart disease (SVHD)including SVHD subjects who have undergone Fontan Palliation; providing a website featuring information in the field of health and wellness; providing a website featuring medical information in the field of cardiac issues; medical testing servicesproviding medical testing services and information in the field of the treatment of cardiac disease and disorderssingle ventricle heart disease (SVHD)including SVHD subjects who have undergone Fontan Palliation for diagnostic or treatment purposes
Publications
History of USPTO decisions and trademark events.
46 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/23/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/23/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
08/23/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/23/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/23/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/29/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/29/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/29/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/29/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/29/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/29/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/04/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/16/2021
PUBO
PUBLISHED FOR OPPOSITION
02/16/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/27/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
01/14/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/29/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/29/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/02/2020
GNRT
NON-FINAL ACTION E-MAILED
07/02/2020
CNRT
NON-FINAL ACTION WRITTEN
07/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/25/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/10/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/10/2020
CNSI
SUSPENSION INQUIRY WRITTEN
02/10/2020
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/10/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/02/2019
GNSL
LETTER OF SUSPENSION E-MAILED
08/02/2019
CNSL
SUSPENSION LETTER WRITTEN
08/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/31/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/31/2019
ALIE
ASSIGNED TO LIE
07/29/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/24/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/24/2019
GNRT
NON-FINAL ACTION E-MAILED
01/24/2019
CNRT
NON-FINAL ACTION WRITTEN
01/24/2019
DOCK
ASSIGNED TO EXAMINER
01/22/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/28/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/27/2018
NWAP
NEW APPLICATION ENTERED
11/12/2018
Continuous trademark protection
Get notified about every new filing that threatens MEZZION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.